These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20661740)

  • 21. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity.
    Incaprera M; Rindi L; Bazzichi A; Garzelli C
    Clin Exp Rheumatol; 1998; 16(3):289-94. PubMed ID: 9631751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Possible Effect of B-Cell Epitopes of Epstein-Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus.
    Tu J; Wang X; Geng G; Xue X; Lin X; Zhu X; Sun L
    Front Immunol; 2018; 9():187. PubMed ID: 29497417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus and disease activity in multiple sclerosis.
    Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated antinuclear antibodies and altered anti-Epstein-Barr virus immune responses.
    Cuomo L; Cirone M; Di Gregorio AO; Vitillo M; Cattivelli M; Magliocca V; Maiorano S; Meledandri M; Scagnolari C; La Rocca S; Trivedi P
    Virus Res; 2015 Jan; 195():95-9. PubMed ID: 25300805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient evaluation of humoral immune responses by the use of serum pools.
    Sternbæk L; Draborg AH; Nielsen CT; Jacobsen S; Iversen LV; Troelsen L; Theander E; Houen G
    J Immunol Methods; 2017 Apr; 443():1-8. PubMed ID: 28130033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic.
    Agmon-Levin N; Dagan A; Peri Y; Anaya JM; Selmi C; Tincani A; Bizzaro N; Stojanovich L; Damoiseaux J; Cohen Tervaert JW; Mosca M; Cervera R; Shoenfeld Y
    Clin Exp Rheumatol; 2017; 35(6):929-935. PubMed ID: 28770708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus Patients.
    Draborg AH; Sandhu N; Larsen N; Lisander Larsen J; Jacobsen S; Houen G
    J Immunol Res; 2016; 2016():6473204. PubMed ID: 27110576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site.
    Csorba K; Schirmbeck LA; Tuncer E; Ribi C; Roux-Lombard P; Chizzolini C; Huynh-Do U; Vanhecke D; Trendelenburg M
    Front Immunol; 2019; 10():2619. PubMed ID: 31787984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature.
    Ramos-Casals M; Cuadrado MJ; Alba P; Sanna G; Brito-Zerón P; Bertolaccini L; Babini A; Moreno A; D'Cruz D; Khamashta MA
    Medicine (Baltimore); 2008 Nov; 87(6):311-318. PubMed ID: 19011502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. INFECTIOUSNESS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS.
    Guta S; Abrahamovych O; Abrahamovych U; Tsyhanyk L; Farmaha M
    Georgian Med News; 2023 May; (338):121-125. PubMed ID: 37419485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple sclerosis and Epstein-Barr virus.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.
    Csuka D; Simon D; Hóbor R; Uray K; Prohászka Z; Bánlaki Z; Jani PK; Szilágyi Á; Hudecz F; Rajczy K; Beke G; Boros Major A; Tordai A; Illés Z; Berki T; Czirják L; Füst G
    Clin Exp Immunol; 2013 Mar; 171(3):255-62. PubMed ID: 23379431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral markers of active Epstein-Barr virus infection associate with anti-extractable nuclear antigen autoantibodies and plasma galectin-3 binding protein in systemic lupus erythematosus.
    Rasmussen NS; Nielsen CT; Houen G; Jacobsen S
    Lupus; 2016 Dec; 25(14):1567-1576. PubMed ID: 27084029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus.
    Banko A; Cirkovic A; Miskovic R; Jeremic I; Grk M; Basaric M; Lazarevic I; Raskovic S; Despotovic A; Miljanovic D
    Front Immunol; 2023; 14():1307589. PubMed ID: 38146370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus.
    McClain MT; Poole BD; Bruner BF; Kaufman KM; Harley JB; James JA
    Arthritis Rheum; 2006 Jan; 54(1):360-8. PubMed ID: 16385527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody responses against polypeptide components of Epstein-Barr virus-induced early diffuse antigen in patients with connective tissue diseases.
    Ngou J; Segondy M; Seigneurin JM; Graafland H
    J Med Virol; 1990 Sep; 32(1):39-46. PubMed ID: 2173736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
    PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
    Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M
    J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.